BA
AGRX

BlackRock Advisors’s Agile Therapeutics AGRX Stock Holding History

BlackRock Advisors’s Portfolio AGRX Stock Details AGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$27K Hold
2
– – ﹤0.01% 3397
2016
Q3 		$31K Hold
2
– – ﹤0.01% 3361
2016
Q2 		$34K Hold
2
– – ﹤0.01% 3328
2016
Q1 		$28K Buy
2
+1
+100% +$12.9K ﹤0.01% 3352
2015
Q4 		$27K Sell
1
-2
-67% -$31.6K ﹤0.01% 3410
2015
Q3 		$34K Hold
3
– – ﹤0.01% 3398
2015
Q2 		$44K Buy
+3
New +$64K ﹤0.01% 3346

Other funds holding AGRX

PAI
ProQuest Associates IV Naples, Florida $53M AUM 3.35% 1-Year Est. Return
IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
CC
Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return
AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

BlackRock Advisors's AGRX Position: Q4 2016 in Review

BlackRock Advisors held its Agile Therapeutics (AGRX) position steady in Q4 2016 at 2 shares worth $27K. The position accounts for ﹤0.01% of the portfolio, ranked #3397.

BlackRock Advisors first reported a position in AGRX in Q2 2015 and has held it in 7 quarters since. The position peaked at $44K in Q2 2015. 62 funds tracked by Wall St. Rank hold AGRX as of Q4 2016.

  • BlackRock Advisors held 2 shares of Agile Therapeutics worth $27K as of Q4 2016.
  • BlackRock Advisors left its Agile Therapeutics share count unchanged in Q4 2016.
  • Agile Therapeutics made up ﹤0.01% of BlackRock Advisors's portfolio in Q4 2016, its #3397 holding.
  • BlackRock Advisors first reported a position in Agile Therapeutics in Q2 2015 and has held it in 7 quarters since.
  • BlackRock Advisors's Agile Therapeutics position peaked at $44K in Q2 2015.
  • 62 funds tracked by Wall St. Rank held Agile Therapeutics as of Q4 2016.

Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.